Evaluation of nimodipine in the treatment of severe diffuse head injury

A double-blind placebo-controlled trial

Shibu V. Pillai, V. R S Kolluri, Aaron Mohanty, B. A. Chandramouli

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Aims: The aim of this study was to establish whether nimodipine given orally soon after severe diffuse head injury for a period of three weeks improved outcome. Material and methods: The present report analyzes the results of a prospective randomized double-blind placebo-controlled trial of nimodipine in 97 severe head injury patients (GCS Score <\=8) treated at the Department of Neurosurgery, NIMHANS, between January 1995 and June 1996. The patients were randomly assigned to two groups which were matched for age, sex, mode of injury, time interval from injury to admission, neurological status and CT scan findings. One group was given nimodipine 30 mg Q6H and the other group was given a placebo. The outcome of these patients at 6 months was evaluated using the Glasgow Outcome Score by and a psychologist. Results: Results showed no significant difference in the functional and psychological outcome between the two groups, even in patients with subarachnoid hemorrhage. No adverse drug events were recorded. Conclusion: Oral nimodipine given for three weeks does not improve outcome in patients with severe diffuse head injury.

Original languageEnglish (US)
Pages (from-to)361-363
Number of pages3
JournalNeurology India
Volume51
Issue number3
StatePublished - Sep 2003
Externally publishedYes

Fingerprint

Nimodipine
Craniocerebral Trauma
Placebos
Psychology
Therapeutics
Wounds and Injuries
Neurosurgery
Subarachnoid Hemorrhage
Drug-Related Side Effects and Adverse Reactions

Keywords

  • Diffuse head injury
  • Nimodipine
  • Outcome

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Evaluation of nimodipine in the treatment of severe diffuse head injury : A double-blind placebo-controlled trial. / Pillai, Shibu V.; Kolluri, V. R S; Mohanty, Aaron; Chandramouli, B. A.

In: Neurology India, Vol. 51, No. 3, 09.2003, p. 361-363.

Research output: Contribution to journalArticle

Pillai, Shibu V. ; Kolluri, V. R S ; Mohanty, Aaron ; Chandramouli, B. A. / Evaluation of nimodipine in the treatment of severe diffuse head injury : A double-blind placebo-controlled trial. In: Neurology India. 2003 ; Vol. 51, No. 3. pp. 361-363.
@article{f2aa1b29a9cc490c92c42b23b976bd49,
title = "Evaluation of nimodipine in the treatment of severe diffuse head injury: A double-blind placebo-controlled trial",
abstract = "Aims: The aim of this study was to establish whether nimodipine given orally soon after severe diffuse head injury for a period of three weeks improved outcome. Material and methods: The present report analyzes the results of a prospective randomized double-blind placebo-controlled trial of nimodipine in 97 severe head injury patients (GCS Score <\=8) treated at the Department of Neurosurgery, NIMHANS, between January 1995 and June 1996. The patients were randomly assigned to two groups which were matched for age, sex, mode of injury, time interval from injury to admission, neurological status and CT scan findings. One group was given nimodipine 30 mg Q6H and the other group was given a placebo. The outcome of these patients at 6 months was evaluated using the Glasgow Outcome Score by and a psychologist. Results: Results showed no significant difference in the functional and psychological outcome between the two groups, even in patients with subarachnoid hemorrhage. No adverse drug events were recorded. Conclusion: Oral nimodipine given for three weeks does not improve outcome in patients with severe diffuse head injury.",
keywords = "Diffuse head injury, Nimodipine, Outcome",
author = "Pillai, {Shibu V.} and Kolluri, {V. R S} and Aaron Mohanty and Chandramouli, {B. A.}",
year = "2003",
month = "9",
language = "English (US)",
volume = "51",
pages = "361--363",
journal = "Neurology India",
issn = "0028-3886",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "3",

}

TY - JOUR

T1 - Evaluation of nimodipine in the treatment of severe diffuse head injury

T2 - A double-blind placebo-controlled trial

AU - Pillai, Shibu V.

AU - Kolluri, V. R S

AU - Mohanty, Aaron

AU - Chandramouli, B. A.

PY - 2003/9

Y1 - 2003/9

N2 - Aims: The aim of this study was to establish whether nimodipine given orally soon after severe diffuse head injury for a period of three weeks improved outcome. Material and methods: The present report analyzes the results of a prospective randomized double-blind placebo-controlled trial of nimodipine in 97 severe head injury patients (GCS Score <\=8) treated at the Department of Neurosurgery, NIMHANS, between January 1995 and June 1996. The patients were randomly assigned to two groups which were matched for age, sex, mode of injury, time interval from injury to admission, neurological status and CT scan findings. One group was given nimodipine 30 mg Q6H and the other group was given a placebo. The outcome of these patients at 6 months was evaluated using the Glasgow Outcome Score by and a psychologist. Results: Results showed no significant difference in the functional and psychological outcome between the two groups, even in patients with subarachnoid hemorrhage. No adverse drug events were recorded. Conclusion: Oral nimodipine given for three weeks does not improve outcome in patients with severe diffuse head injury.

AB - Aims: The aim of this study was to establish whether nimodipine given orally soon after severe diffuse head injury for a period of three weeks improved outcome. Material and methods: The present report analyzes the results of a prospective randomized double-blind placebo-controlled trial of nimodipine in 97 severe head injury patients (GCS Score <\=8) treated at the Department of Neurosurgery, NIMHANS, between January 1995 and June 1996. The patients were randomly assigned to two groups which were matched for age, sex, mode of injury, time interval from injury to admission, neurological status and CT scan findings. One group was given nimodipine 30 mg Q6H and the other group was given a placebo. The outcome of these patients at 6 months was evaluated using the Glasgow Outcome Score by and a psychologist. Results: Results showed no significant difference in the functional and psychological outcome between the two groups, even in patients with subarachnoid hemorrhage. No adverse drug events were recorded. Conclusion: Oral nimodipine given for three weeks does not improve outcome in patients with severe diffuse head injury.

KW - Diffuse head injury

KW - Nimodipine

KW - Outcome

UR - http://www.scopus.com/inward/record.url?scp=0348143414&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0348143414&partnerID=8YFLogxK

M3 - Article

VL - 51

SP - 361

EP - 363

JO - Neurology India

JF - Neurology India

SN - 0028-3886

IS - 3

ER -